Show simple item record

dc.contributor.authorSalih, Niven A
dc.contributor.authorvan Griensven, Johan
dc.contributor.authorChappuis, François
dc.contributor.authorAntierens, Annick
dc.contributor.authorMumina, Ann
dc.contributor.authorHammam, Omar
dc.contributor.authorBoulle, Philippa
dc.contributor.authorAlirol, Emilie
dc.contributor.authorAlnour, Mubarak
dc.contributor.authorElhag, Mousab S
dc.contributor.authorManzi, Marcel
dc.contributor.authorKizito, Walter
dc.contributor.authorZachariah, Rony
dc.date.accessioned2014-03-24T21:59:28Z
dc.date.available2014-03-24T21:59:28Z
dc.date.issued2014-02
dc.identifier.citationLiposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? 2014, 19 (2):146-52 Trop. Med. Int. Healthen_GB
dc.identifier.issn1365-3156
dc.identifier.pmid24433217
dc.identifier.doi10.1111/tmi.12238
dc.identifier.urihttp://hdl.handle.net/10144/314577
dc.description.abstractThe aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan.
dc.language.isoenen
dc.publisherJohn Wiley & Sons Ltden_GB
dc.rightsArchived on this site with the kind permission of Wiley-Blackwell, [url]http://www.blackwell-synergy.com/loi/tmi[/url]en_GB
dc.subjectKala Azar/Visceral Leishmaniasisen_GB
dc.subjectOperational Researchen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAdulten_GB
dc.subject.meshAmphotericin Ben_GB
dc.subject.meshChilden_GB
dc.subject.meshChild, Preschoolen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshInfanten_GB
dc.subject.meshLeishmania donovanien_GB
dc.subject.meshLeishmaniasis, Visceralen_GB
dc.subject.meshLost to Follow-Upen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshNeglected Diseasesen_GB
dc.subject.meshPregnancyen_GB
dc.subject.meshPregnancy Complications, Parasiticen_GB
dc.subject.meshRecurrenceen_GB
dc.subject.meshSudanen_GB
dc.subject.meshTreatment Failureen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.subject.meshTrypanocidal Agentsen_GB
dc.subject.meshYoung Adulten_GB
dc.titleLiposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?en
dc.identifier.journalTropical Medicine & International Health : TM & IHen_GB
refterms.dateFOA2019-03-04T11:06:57Z
html.description.abstractThe aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan.


Files in this item

Thumbnail
Name:
Salih et al-2014-Liposomal ...
Size:
114.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record